Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Don Dunlap who wrote (2609)	5/19/1998 4:12:00 PM
From: Barron Von Hymen	Read Replies (2) \| Respond to of 9523

Typical margins for PFE has been 18% of sales for last few quarters.

To: Don Dunlap who wrote (2609)	5/19/1998 9:14:00 PM
From: Uncle Frank	Read Replies (1) \| Respond to of 9523

>>I am curious because some estimates have Pfizer at a 2Billion dollar a year drug. If it costs $1 to produce and distribute a $10 pill, this could add 1.8 Billion pre tax to the net income. This would almost quadruple the current net income. I'm a little confused by your math. Even if Pfizer made 90% margins on Viagra and added $1.8B to pretax, and even if they didn't have to pay any taxes, it wouldn't quadruple their ttm earnings of $2.213B. Viagra is BIG, but Pfizer is already HUGE!